RAIFF yields 2.65% · JNJ yields 2.13%● Live data
📍 RAIFF pulled ahead of the other in Year 1
Combined, RAIFF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of RAIFF + JNJ for your $10,000?
Raiffeisen Bank International AG, together with its subsidiaries, provides corporate, retail, and investment banking services. The company offers cross border accounts; and cash management services, such as account, reporting, payment, clearing, settlement, and cash pooling services; electronic banking; and SEPA and cross-border payments to billing solutions. It also provides investor services, including custody and fund administration services, as well as execution services comprising electronic sales trading, direct market access, and fund brokerage services; trade, working capital, export, sustainable, and real estate finance services, as well as commodity and structured trade, project, and supply chain finance products; and cards. In addition, the company offers bank guarantees, sureties, and letters of credit, as well as documentary collection products; hedging, factoring, and leasing services; and fixed income, money market and securities, asset management, and structured products for corporate and institutional customers. Further, it arranges syndicated loans and structure asset based finance transactions; and assists clients in mergers, acquisitions, sales, and privatizations. As of December 31, 2020, the company operated through a network of 1,857 business outlets in Central, Southeastern, and Eastern Europe. Raiffeisen Bank International AG was founded in 1886 and is headquartered in Vienna, Austria.
Full RAIFF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.